Redeye leaves a comment on CLS following today's update regarding its new sterilization supplier and the resumption of the prostate cancer s...
Redeye views the first commercial order from Germany as intriguing.
Patentansökan för KebNis första egenutvecklade inertial sensing-applikation öppnar dörren för en hel...
Finnair reports Q2 results on Jul 15. Capacity is being scaled up while passenger numbers have bottomed out, but there’s a lot of uncertaint...
During the first half of 2020, M&A activity in the metals and mining industry declined drastically.
Redeye bedömer att sannolikheten för godkännande av lecanemab har ökat från 55% till 63% och justera...
Idag, 2021-07-09, meddelade Neodynamics att den första beställningen på ett NeoNavia-system erhållits från Tyskland.
Redeye raises the likelihood of approval for lecanemab from 55% to 63% and adjusts the price of leca...
Redeyes main takeaway is that Nanologica adds support (pharma companies) in Drug Development and add...
Footway Group's Q2 sales came in SEK 17m or 4% below our forecast for a growth of 32% y-o-y.
Acquires IVF diagnostics company Igenomix Pays 36x LTM EV/EBITDA Pre-announced Q2’21 – CER sales gro...
CapMan has guided for two new fundraising projects for 2021 targeting international investors specif...
Q2 to show strong improvements in PBLL y-o-y We now expect EO DPS of DKK 47 alongside Q2 Trading at ...
Recurring PTP up 2% y-o-y, SEK 247m, -7% v. ABGSCe Large value uplifts following sector-wide yield shift TTM P/CE of 24.
Ahead of CDON’s Q2 2021 results, we downgrade our GMV forecasts, reflecting muted site traffic data ...
Talenom announced today that it has acquired Spanish accounting firm Avail Services SL in Barcelona ...
We have looked at the Finnish accounting service market and we continue to view Talenom’s business model as the winning one in this field.
Redeye leaves a short comment following the capital injection of SEK 14,4m before transaction costs ...
Mangold inleder bevakning av teknikbolaget Smoltek med Köp och riktkursen 71,00 kronor på 12 månader...
We adjust our base case of Nanexa following the company’s completed rights issue.
Vi inleder bevakning av Rottneros. Vi initierar bevakning av Rottneros, en svensk producent av markn...
Q2 report on Tuesday, 20 July at 08:00 CET EBITA up 6% ‘21e-‘23e on higher margin assumptions 12x EV...
Modus Therapeutics har utvecklat en läkemedelskandidat, sevuparin, mot sepsis, eller blodförgiftning.
Preliminary result of the mandatory bid is out Bid accepted for just 6.
Mangold tar upp IT-företaget Qlosr Group till bevakning med en riktkurs på 0,13 kronor per aktie oc...
Gigger publicerar den 27 augusti sin delårsrapport för årets andra kvartal.
Strong Q2’21e order intake of DKK 3.5bn Underlying momentum for new orders continues We reiterate ou...
We see organic growth continuing in Q2e (+16%) FX headwind to be expected (-9% vs.
